Evidence map›Paper›PMID 35517358›Full record

ArticleRSC advances2020

Fluorenone imidazolium salts as novel de Vries materials.

Korinna Bader, Carsten Müller, Yann Molard, Angelika Baro, Philipp Ehni, Jakob Knelles, Sabine Laschat

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Korinna BaderInstitut für Organische Chemie, Universität Stuttgart Pfaffenwaldring 55 70569 Stuttgart Germany sabine.laschat@oc.uni-stuttgart.de.
Carsten MüllerInstitut für Physikalische Chemie, Universität Stuttgart Pfaffenwaldring 55 70569 Stuttgart Germany.
Yann MolardCNRS, ISCR-UMR 6226, ScanMAT-UMS 2001, University Rennes 35000 Rennes France yann.molard@univ-rennes1.fr.ORCID https://orcid.org/0000-0002-6295-0883
Angelika BaroInstitut für Organische Chemie, Universität Stuttgart Pfaffenwaldring 55 70569 Stuttgart Germany sabine.laschat@oc.uni-stuttgart.de.
Philipp EhniInstitut für Organische Chemie, Universität Stuttgart Pfaffenwaldring 55 70569 Stuttgart Germany sabine.laschat@oc.uni-stuttgart.de.
Jakob KnellesInstitut für Organische Chemie, Universität Stuttgart Pfaffenwaldring 55 70569 Stuttgart Germany sabine.laschat@oc.uni-stuttgart.de.
Sabine LaschatInstitut für Organische Chemie, Universität Stuttgart Pfaffenwaldring 55 70569 Stuttgart Germany sabine.laschat@oc.uni-stuttgart.de.ORCID https://orcid.org/0000-0002-1488-3903
University of Stuttgart · DECentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In ionic liquid crystals (ILCs) tilted mesophases such as SmC required for electro-optic devices are quite rare. We report a design concept that induced the SmC phase and enabled de Vries-like behaviour in ILCs. For this purpose, we synthesized and characterized a library of ILC derivatives ImR(On,Ym)X which consist of a rigid central fluorenone core containing an alkoxy or thioether side chain and connected

Identifiers

PMID35517358
PMCPMC9055108
OpenAlexW3036004130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.